Advertisement
Advertisement

Borregaard ASA Reports Q3 2025 Financial Results Amid Operational Challenges

Story Highlights
Borregaard ASA Reports Q3 2025 Financial Results Amid Operational Challenges

Meet Your ETF AI Analyst

The latest announcement is out from Borregaard ASA ( (GB:0QB7) ).

Borregaard ASA reported a decrease in operating revenues and EBITDA for the third quarter of 2025, primarily due to lower bioethanol prices and a temporary disruption in cellulose production. Despite these challenges, the company saw growth in its BioSolutions segment, driven by increased agricultural sales, showcasing the resilience and adaptability of its business model.

The most recent analyst rating on (GB:0QB7) stock is a Hold with a NOK220.00 price target. To see the full list of analyst forecasts on Borregaard ASA stock, see the GB:0QB7 Stock Forecast page.

More about Borregaard ASA

Borregaard ASA operates in the bio-based industry, focusing on the production of advanced and sustainable biochemicals and biomaterials. The company is known for its innovative solutions in BioSolutions, BioMaterials, and Fine Chemicals, with a strong emphasis on agricultural applications.

Average Trading Volume: 55,315

Current Market Cap: NOK19.44B

See more insights into 0QB7 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1